- ¥800 - 1380
- HZbscience
- 中国/美国/德国
- HZ0139
- 2025年07月08日
13 年钻石会员
企业认证
相关产品推荐更多 >
![载体pGL4.35[luc2P/9XGAL4UAS/Hygro]](https://img1.dxycdn.com/2017/0807/019/3225684503025994513-14.jpg!wh200)
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 保存条件：
-20℃
- 保质期：
半年
- 英文名：
pDsRed2-N1
- 库存：
200
- 供应商：
沪震生物
- 规格：
5ug
pDsRed2-N1
产品信息
| 产品货号 | 产品名称 | 产品规格 | 优惠价 |
|---|---|---|---|
| HZ0139 | pDsRed2-N1 | 5μg |
¥请询价 |
使用说明
沪震质粒平台的各批次质粒菌株发货前均经过严格的多重验证，如存在质量问题，请在收到产品的三个月内通知我司。收到质粒后请短暂离心，取2μl转化至对应感受态中，挑取单克隆重新提取质粒后使用。
基本信息
| 启动子: | CMV promoter |
|---|---|
| 复制子: | pUC ori,f1 ori |
| 终止子: | SV40 poly(A) signal |
| 质粒分类: | 哺乳系列质粒；哺乳荧光质粒；哺乳红色质粒 |
| 质粒大小: | 4689bp |
| 质粒标签: | C-DsRed2 |
| 原核抗性: | 卡那霉素Kan（50μg/ml） |
| 筛选标记: | 新霉素Neo/G418 |
| 克隆菌株: | DH5α等大肠杆菌 |
| 培养条件: | 37℃，有氧 LB |
| 表达宿主: | 293T等哺乳细胞 |
| 诱导方式: | 无须诱导，瞬时表达 |
| 5'测序引物: | CMV-F（CGCAAATGGGCGGTAGGCGTG） |
| 3'测序引物: | Sv40-polyA-R (GAAATTTGTGATGCTATTGC) |
| 备注: | 哺乳细胞红色荧光表达载体 |
质粒简介
pDsRed2-N1编码DsRed2，是一种DsRed变体，其设计用于更快的成熟和较低的非特异性聚集。衍生自Discosoma sp。红色荧光蛋白DsRed2，如其祖细胞DsRed1，含有一系列沉默的碱基对变化，对应于哺乳动物细胞中高表达的人类密码子使用偏好。除了这些变化外，DsRed2含有六个氨基酸取代：V105A，I161T和S197A，导致转染细胞系中红色荧光的出现更加快速;和R2A，K5E和K9T，其阻止蛋白质聚集。（DsRed2可能与DsRed1形成相同的四聚体结构。）在DsRed2组成型表达的哺乳动物细胞培养物中，转染后24小时内可通过荧光显微镜检测发红细胞。在表达DsRed1的细胞和哺乳动物细胞系统中经常观察到的蛋白质的大不溶性聚集体在表达DsRed2的细胞中显着降低。更快成熟，更可溶性的红色荧光蛋白也被宿主细胞耐受良好;用DsRed2转染的哺乳动物细胞培养物没有显示生存力降低的明显迹象，在测试的那些细胞系中，表达DsRed2的细胞显示与非转染对照相同的形态（例如粘附，光折射）和生长特征。
pDsRed2-N1 encodes DsRed2, a DsRed variant that has been engineered for faster maturation and lower non-specific aggregation. Derived from the Discosoma sp. red fluorescent protein (drFP583; 1), DsRed2, like its progenitor DsRed1, contains a series of silent base-pair changes that correspond to human codon-usage preferences for high expression in mammalian cells (2). In addition to these changes, DsRed2 contains six amino acid substitutions: V105A, I161T, and S197A, which result in the more rapid appearance of red fluorescence in transfected cell lines; and R2A, K5E, and K9T, which prevent the protein from aggregating. (DsRed2 may, however, form the same tetrameric structure as DsRed1 [3].) In mammalian cell cultures when DsRed2 is expressed constitutively, red-emitting cells can be detected by fluorescence microscopy within 24 hours of transfection. Large insoluble aggregates of protein, often observed in bacterial and mammalian cell systems expressing DsRed1, are dramatically reduced in cells expressing DsRed2. The faster-maturing, more soluble red fluorescent protein is also well tolerated by host cells; mammalian cell cultures transfected with DsRed2 show no obvious signs of reduced viability—in those cell lines tested, cells expressing DsRed2 display the same morphology (e.g., adherence, light-refraction) and growth characteristics as non-transfected controls.
The multiple cloning site (MCS) in pDsRed2-N1 is positioned between the immediate early promoter of CMV (PCMV IE) and the DsRed2 coding sequence. Genes cloned into the MCS are expressed as fusions to the N-terminus of DsRed2. Sequences upstream of DsRed2 have been converted to a Kozak consensus translation initiation site to increase translation efficiency in eukaryotic cells (4). SV40 polyadenylation signals ownstream of the DsRed2 gene direct proper processing of the 3' end of the DsRed2 mRNA. The vector backbone contains an SV40 origin for replication in mammalian cells expressing the SV40 T antigen, a pUC origin of replication for propagation in E. coli, and an f1 origin for single-stranded DNA production. A neomycin-resistance cassette (Neor) allows stably transfected eukaryotic cells to be selected using G418. This cassette consists of the SV40 early promoter, the neomycin/kanamycin resistance gene of Tn5, and polyadenylation signals from the Herpes simplex virus thymidine kinase (HSV TK) gene. A bacterial promoter upstream of the cassette confers kanamycin resistance to E. coli.
pDsRed2-N1 can be used to construct fusions to the N-terminus of DsRed2. If a fusion construct retains the fluorescent properties of the native DsRed2 protein, its expression can be monitored by flow cytometry and its localization in vivo can be determined by fluorescence microscopy. The target gene should be cloned into pDsRed2-N1 so that it is in frame with the DsRed2 coding sequence, with no intervening in-frame stop codons. The inserted gene should include an initiating ATG codon. Recombinant pDsRed2-N1 can be transfected into mammalian cells using any standard transfection method. If required, stable transfectants can be selected using G418 (5). Unmodified pDsRed2-N1 can also be used to express DsRed2 in a cell line of interest (e.g., for use as a transfection marker).
The multiple cloning site (MCS) in pDsRed2-N1 is positioned between the immediate early promoter of CMV (PCMV IE) and the DsRed2 coding sequence. Genes cloned into the MCS are expressed as fusions to the N-terminus of DsRed2. Sequences upstream of DsRed2 have been converted to a Kozak consensus translation initiation site to increase translation efficiency in eukaryotic cells (4). SV40 polyadenylation signals ownstream of the DsRed2 gene direct proper processing of the 3' end of the DsRed2 mRNA. The vector backbone contains an SV40 origin for replication in mammalian cells expressing the SV40 T antigen, a pUC origin of replication for propagation in E. coli, and an f1 origin for single-stranded DNA production. A neomycin-resistance cassette (Neor) allows stably transfected eukaryotic cells to be selected using G418. This cassette consists of the SV40 early promoter, the neomycin/kanamycin resistance gene of Tn5, and polyadenylation signals from the Herpes simplex virus thymidine kinase (HSV TK) gene. A bacterial promoter upstream of the cassette confers kanamycin resistance to E. coli.
pDsRed2-N1 can be used to construct fusions to the N-terminus of DsRed2. If a fusion construct retains the fluorescent properties of the native DsRed2 protein, its expression can be monitored by flow cytometry and its localization in vivo can be determined by fluorescence microscopy. The target gene should be cloned into pDsRed2-N1 so that it is in frame with the DsRed2 coding sequence, with no intervening in-frame stop codons. The inserted gene should include an initiating ATG codon. Recombinant pDsRed2-N1 can be transfected into mammalian cells using any standard transfection method. If required, stable transfectants can be selected using G418 (5). Unmodified pDsRed2-N1 can also be used to express DsRed2 in a cell line of interest (e.g., for use as a transfection marker).
质粒图谱
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验相关实验
maoliping70：pEGFP-N1为载体表达的核蛋白要确证表达于核内的方法为用PI染色，PI只与核酸结合，在488nm激发下发红光，而GFP发绿光，红光与绿光重叠发黄光。还有以下疑问：1.作为对照的pEGFP-N1空载体转染细胞后表达的GFP蛋白为27KD，能自由通过核孔复合体，也就是说GFP在核内也有表达，那会与PI重叠发黄光影响测定吗？2.有提出GFP在细胞固定时，会从细胞漏出，那细胞本身表达的浆蛋白若分子量小，也会漏出吗？还是因为有定位信号而不漏出？3.细胞固定用的70%乙醇是直接
是由IRES序列行使功能的，但要注意的是，这部分的翻译水平比较低，比前面的MCSA大概低一个数量级。所以要选择好两个蛋白的各自位置。 3)、哺乳动物/真核荧光载体 pEGFP-N1 pEGFPN1 表达 绿色 荧光蛋白和目的基因的融合蛋白，目的基因位于N端 kan/neo 4.7kb E. coli/mammals pEGFP-N3 pEGFPN3 表达 绿色 荧光蛋白和目的基因的融合蛋白，目的基因位于N端 kan/neo 4.7kb E. coli/mammals pEGFP
影响的。 ono1180 我想问一下，除了正规公司，什么地方能求购到比较便宜，又能够保真的质粒 lisail 我有PLEGFP-N1的病毒载体，需要的话联系我Q2427657955 本文由丁香园论坛提供，想了解更多有用的、有意思的前沿资讯以及酷炫的实验方法的你，都可以成为师兄的好伙伴 师兄微信号：shixiongcoming
技术资料暂无技术资料 索取技术资料
载体pDsRed2-N1
¥800 - 1380
